Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Gastrointestinal 3Thoracic 1Sarcoma 1Other solid neoplasm 1

Conditions

Rectal Neoplasms 1Carcinoma, Hepatocellular 1Advanced Pancreatic Cancer 1

Interventions

Oxaliplatin 300Fluorouracil 273Gemcitabine 238Bevacizumab 235Leucovorin 212Capecitabine 207pembrolizumab 201Irinotecan 159Nivolumab 158Cisplatin 151Specimen Handling 143Magnetic Resonance Spectroscopy 129130-nm albumin-bound paclitaxel 118Paclitaxel 109durvalumab 106Cetuximab 104Radiotherapy 99Drug Therapy 94atezolizumab 93Biopsy 92tislelizumab 81Albumin-Bound Paclitaxel 81Taxes 75lenvatinib 67Folfox protocol 67Carboplatin 66regorafenib 61Blood Specimen Collection 60sintilimab 54Ipilimumab 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
penpulimab × Gastrointestinal × 1 year × Clear all
NCT06821503 2026-03-10

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Recruiting
72 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

NCT05576480 2025-08-28

SPARC

Ruijin Hospital

Phase 2 Recruiting
55 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07075419 2025-07-20

JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure

West China Hospital

Phase 1/2 Not yet recruiting
10 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡